Kenfarb & Co’s AbbVie ABBV Stock Holding History

Kenfarb & Co’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.6M	Hold	10,750	–	–	1.47%	20
2023 Q2	$1.45M	Hold	10,750	–	–	1.26%	25
2023 Q1	$1.71M	Sell	10,750 -150	-1%	-$22.9K	1.53%	20
2022 Q4	$1.76M	Hold	10,900	–	–	1.56%	21
2022 Q3	$1.46M	Buy	10,900 +190	+2%	+$27.3K	1.39%	25
2022 Q2	$1.74M	Hold	10,710	–	–	1.37%	25
2022 Q1	$1.74M	Buy	10,710 +1,700	+19%	+$247K	1.37%	25
2021 Q4	$1.22M	Buy	+9,010	New	+$1.06M	0.89%	34

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kenfarb & Co's ABBV Position: Q3 2023 in Review

Kenfarb & Co held its AbbVie (ABBV) position steady in Q3 2023 at 10,750 shares worth $1.6M. The position accounts for 1.47% of the portfolio, ranked #20.

Kenfarb & Co first reported a position in ABBV in Q4 2021 and has held it in 8 quarters since. The position peaked at $1.76M in Q4 2022. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

Kenfarb & Co held 10,750 shares of AbbVie worth $1.6M as of Q3 2023.
Kenfarb & Co left its AbbVie share count unchanged in Q3 2023.
AbbVie made up 1.47% of Kenfarb & Co's portfolio in Q3 2023, its #20 holding.
Kenfarb & Co first reported a position in AbbVie in Q4 2021 and has held it in 8 quarters since.
Kenfarb & Co's AbbVie position peaked at $1.76M in Q4 2022.
3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Kenfarb & Co's 13F filing for Q3 2023, filed 14 Nov 2023.